Comparison of prothiadene and chorprotixene in neurtoic inpatients.
D000328:Adult; D001007:Anxiety / Q000188:drug therapy; D002749:Chlorprothixene / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003988:Dibenzothiepins / Q000627:therapeutic use*; D005260:Female; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010698:Phobic Disorders / Q000188:drug therapy; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011602:Psychophysiologic Disorders / Q000188:drug therapy
D003988:Dibenzothiepins; D010919:Placebos; D002749:Chlorprothixene